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Penicillin, with or without fever, is rapidly replacing other drugs in the manage-
ment of various types of neurosyphilis (1). Clinical studies assaying this new
drug must rest upon long-term improvements in the clinical picture and changes
in the cerebrospinal fluid. 'While these represent ultimate criteria of effective-
ness, it is of some interest, however, to determine the degree to which penicillin
is spirocheticidal to organisms within the brain and to compare its spirocheticidal
action with that of the older pentavalent and trivalent arsenical drugs. In the
present study we have employed the well known asymptomatic infection in the
white mouse for the assay of penicillin, mapharsen, and tryparsamide, deterS-
mining the amounts of these drugs required to render the mouse's brain non-
infectious. As will be shown, penicillin is an effective therapeutic agent in this
infection, but neither tryparsamide nor mapharsen are curative in doses up to the
maximum tolerated dose.
EXPERIMENTAL
In spite of the extensive literature on asymptomatic syphilis in the white
mouse (2), many variables are still poorly understood. Our own studies were
irregular until a quantitative approach was undertaken, and even now, we do
not have all of the variables in hand. Nevertheless, the work has progressed to
a point justifying the above conclusions, and it is for this reason that the present
report is submitted.
Our first attempts to produce this central nervous system infection in white
mice met with irregular success. As a first step in resolving these irregularities
the following variables were tested: (a) the size of the inoculum and, (b) the
duration of the infection as related to the development of central nervous system
infection. The emulsions for inoculation were prepared from acute rabbit
testicular syphilomatas removed fourteen days after inoculation with 10 T.
pallidum (Nichols strain). These emulsions were calibrated and suitably diluted
by the technic previously described (3) so that the required number of organisms
was contained in 0.2 cc. Sixty-six male, white mice of the CFW and CF1 strains,
weighing between 15 and 20 grams, were inoculated intraperitoneally with 10,
106, and 10 T. pallidum. At the end of 3, 6, 10, and 21 weeks, the mice were
exsanguinated. The cerebrums were carefully removed, emulsified in 0.2 cc. of
50% rabbit serum-saline and inoculated intracutaneously into rabbits. The
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rabbits were inoculated at from one to six intracutaneous sites over the back.
These were examined twice weekly for a three month period and serum from
clinical lesions was examined by darkfield. Only if a darkfield positive lesion
developed at the site of inoculation was the parent mouse considered positive.
The results of these first studies on the course of the infection are shown in
Table 1. It is apparent that the size of the inoculum and the duration of the
TABLE 1
The effect of the size of inoculum and the duration of infection on the development of asympto-
matic neurosyphilis in the white mouse
Male white mice weighing 15—20 grams were inoculated intraperitoneally with the
indicated number of T. pallidum (Nichols strain). At the end of indicated interval, the
mice were exsanguinated, the brain emulsified in 0.2cc 50% rabbit serum-saline and inocu-
lated intracutaneously into rabbits. The rabbits were observed for a three month period
for the development of darkfield positive lesions.
Th[E OP TRANSFER PROM MICE TO NO. T. PALLID6JM
10
106
10
NO. MICE TRANSPERRED
6
6
6
NO. P01.
2
0
0
NO. NEG.
4
6
6
3weeks
6weeks 10
106
10
6
6
6
2
3
3
4
3
3
10 weeks 10
106
101
4
4
4
4
4
3
0
0
1
21 weeks (brain) 10
106
10
6
6
6
6
6
5
0
0
1
5
6
5
21 weeks (blood)6 10
106
10
6
6
6
1
0
1
* From mice transferred at 21 weeks 0.2 cc. blood was inoculated intracutaneously into
rabbits and observed as in the brain transfers.
infection are both related to the development of the central nervous system in-
fection. The central nervous system infection develops rather slowly, suggest-
ing that some time may be required for the organisms to pass whatever barriers
may exist. It would also appear that the larger the inoculum, the more rapidly
is this barrier passed. In order to determine whether the observed infection was
actually in the brain tissue or whether the apparent infection might simply repre-
sent contamination with blood, 0.2 cc of blood was taken from the mice trans-
ferred at 21 weeks, inoculated intracutaneously into rabbits, and observed in the
same manner as the brain transfers. In these eighteen animals, seventeen of the
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eighteen brain transfers were positive, while but two of the eighteen blood trans-
fers were positive. These results would indicate that the observed infection was
not a happenstance due to blood contamination, but represented a true infection
of the brain.
Following these preliminary studies, therapeutic assays were made on the
central nervous system infection in 116 mice established by the intraperitoneal
inoculation of 106 Treponema pallidum three months prior to treatment. Treat-
ment consisted of either penicillin, mapharsen or tryparsamide. The penicillin
was given as penicillin G in peanut oil beeswax in four daily subcutaneous in-
jections. The size of the animals precluded the use of intramuscular injections.
The mapharsen and tryparsamide were given in a single intraperitoneal injection.
Six weeks after treatment the mice were exsanguinated, the cerebrums removed,
emulsified in 50% rabbit serum, and inoculated intracutaneously into rabbits.
As the study progressed, the original technic of transferring from mouse to
rabbit was slightly modified. The adventitious death of one rabbit could and
did spoil months of work on the mice. In addition, there appeared to be some
variation in susceptibility of the transfer rabbits which might have introduced
additional errors. For these reasons, the transfer technic finally adopted con-
sisted of exsanguinating the mice, emulsifying the brain in 1.0 cc. rather than
0.2 cc. of 50% normal rabbit serum salt and inoculating 0.2 cc. of this emul-
sion into each of five different rabbits. To conserve rabbits, twelve different
sites over the rabbit's back were inoculated with different emulsions, but the
same mouse emulsion was not inoculated at more than one site on the same rab-
bit. As before, the inoculated sites were examined twice weekly for a three
month period and lesions were confirmed by darkfield before considering them
positive.
If any one of the five inoculated sites was positive, the original mouse was con-
sidered positive. The results of these multiple inoculations did not vary from
those in which the brain was not divided and the results are not distinguished
in the Table. It should be noted that following such intracutaneous inoculation,
the inoculated tissue was very slowly absorbed so that a papule remained at the
site of the original inoculation for a three to four week period. Attempts to
demonstrate spirochetes before the end of the fourth week were nearly always
unsuccessful. The most fruitful time period for darkfield examination proved to
be six to eight weeks after inoculation.
The results of treatment in this series of animals are shown in Table 2. It
will be noted that, in contrast to the results anticipated from the previous work
not all of the control animals were infected. Of the control animals transferred
at the beginning of treatment, i.e., 3 months after inoculation, 5 out of 14 (36%)
showed no infection. Of controls transferred at the time the treated mice were
transferred, 3 out of 13 (23%) were not infected. These control results indicate
the need for caution in the interpretation of conventional 50% end points, since
presumably the same proportion of treated animals originally escaped infection.
It is at once apparent that penicillin is the only drug showing therapeutic activ-
ity. At doses from 16,000 U/Kg. and upward significant numbers of the mice
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were cured. The 50% curative dose may be estimated approximately 14,000
units/Kg., and the 90% curative dose at approximately 64,000 units/Kg. With
tryparsamide, doses up to 2,400 mg./Kg. failed to cure significant numbers of
the mice. Mapharsen in doses up to 36 mg./Kg. were similarly unsuccessful.
Since the maximum tolerated dose (5% of the animals killed) of tryparsamide
TABLE 2
The treatment of asymptomatic neurosyphilis in the white mouse
Mice were inoculated intraperitoneally with 106 T. pallidum (Nichols Strain), and treat-
ment given 3 months after inoculation. Mapharsen and tryparsamide were given as single
intraperitoneal injections. Penicillin in peanut oil beeswax was given in four equal daily
subcutaneous injections to the total indicated. Cure was determined six weeks after treat-
ment by transfer of the brain to rabbits. Rabbits were examined for three months after
transfer.
D1tIG
Penicillin
ALOVNT
128,000 U/Kg.
64,000 U/Kg.
32,000 U/Kg.
16,000 U/Kg.
8,000 U/Kg.
z
2
8
8
7
3
d
x
0
2
2
3
5
c
x
100
80
80
70
37
p5
e
100
93
82
59
20
Cflo
14,000 U/Kg.
CDoo'
64,000 U/Kg.
M.T.D.4
Tryparsa-
mide
2,400mg/Kg.
1,200mg./Kg.
600mg./Kg.
300mg./Kg.
2
3
0
1
4
9
6
2
33
25
0
33
60
24
5
4
>2,400mg/Kg. >2,400 mg./Kg. 2,500 mg./Kg.
Maphar-
sen
36mg./Kg.
l8mg./Kg.
Omg./Kg.
4.Smg./Kg.
2
1
3
0
6
7
6
3
25
12
33
0
50
24
14
0
>36 mg./Kg. >36 mg./Kg. 34 mg./Kg.
Controls At time Rx
At time Trans-
fer
5
3
9
10
36
23
36
23
1 After Reed & Muench (13).
2 CD50 = Dose which cured 50% of the animals.
'CD90 = Dose which cured 90% of the animals.
'M.T.D. Maximum tolerated dose (<5% killed) after Eagle et al. (14).
and mapharsen are respectively 2,500 mg./Kg. and 34 mg./Kg., these drugs as
here used would appear to have no therapeutic value.
Objection may be made to the fact that tryparsamide and mapharsen were
given as single injection and that these drugs might have shown activity had
they been given over a longer time period. It has been shown (4) that in rabbits
the curative dose of trivalent arsenicals is approximately the same whether in-
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jections are given as a single injection or spread over many injections. Whether
or not such a finding holds for mice is unknown, but a single large injection would
seem to provide as high a peak blood level as possible and thus provide maximum
opportunity for penetration into the central nervous system. These considera-
tions dictated the somewhat arbitrary choice of a single injection. Whether
multiple injections might be effective remains to be investigated.
It is not known whether the six weeks interval allowed between the termination
of treatment and transfer as a test of cure is adequate. It may be that some of
the animals apparently cured by penicillin would have not been so cured had
transfer been carried out at a later date. Such delayed transfers are in the pro-
cess of study, but cannot be reported at this meeting. Regardless of the reli-
ability of the present method as an absolute criterion of cure, the relative ef-
fectiveness of the three drugs is clear.
DISCUSSION
There have been fragmentary reports on the use of penicillin in mouse syphilis.
Levaditi and Vaisman (5) were the first to employ this drug in 1944, and were
also the authors of later reports appearing in 1945 (6), and 1946 (7). Similarly,
Bessemans and Deron (8) reported in 1945 on eight mice treated with penicillin.
In all of these experiments the number of mice have been few, and the amounts of
penicillin administered have been enormous. The work was well summarized
by Gueft and Rosahn (2) in 1948 who concluded that on the basis of the then
published reports one could not estimate the useful therapeutic efficacy of the
drug in this infection.
The work presently reported has used a schedule known to be effective in other
forms of experimental syphilis (9) and has used dosages within the ranges em-
ployed in the treatment of the human infection. Further, the amounts of peni-
cillin required to cure 50% of the animals and 90% of the animals have been
determined. It has been shown that these amounts are what might be called
reasonable doses and fall within the limits of the penicillin currently given in the
human infection.
It may be of some interest that the penicillin was effective when given in the
peanut oil beeswax media. Ingraham (10) has presented evidence that penicil-
lin in peanut oil beeswax may not be as effective in the prevention of prenatal
syphilis as is the aqueous sodium salt. Presumably this difference is due to the
lower peak blood levels obtained and suggests that the lower peaks obtained with
the peanut oil beeswax may not be sufficiently high to penetrate the placental
barrier. There may be justification for assuming that the same reasoning might
hold in the management of central nervous system infections. While the present
experiment cannot be considered conclusive, the levels afforded by the subcutan-
eous administration of penicillin in peanut oil beeswax were adequate to cure the
central nervous system infection.
In retrospect, it is surprising how little real experimental evidence has sup-
ported the use of tryparsamide in the treatment of central nervous system syphi-
lis. It is now well agreed that the use of trypanosome infections as a criterion
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of treponemacidal activity has many pitfalls, yet most of the older experimental
works (11) supporting the use of tryparsamide, is based upon its activity in try-
panosome infection of rabbits. The work of Raiziss and Severac (12) has been
cited as a therapeutic test of the action of arsphenamine, neoarsphenamine,
bismarsen, tryparsamide, and acetarsone on syphilitic mice. However, their
mouse experiments were concerned with the prevention of invasion of the central
nervous system and did not measure the therapeutic activity against the estab-
lished infection. Since their experiments were concerned with prevention of the
central nervous system infection, it is perhaps not too surprising that their most
effective drug was found to be arsphenamine. Their therapeutic tests were
carried out twenty-four hours after inoculation and the second group two months
after inoculation. Our experiments would indicate that the central nervous
system infection was just becoming established at the latter time period.
SUMMARY
1. The asymptomatic central nervous syphilis of white mice produced by the
intraperitoneal inoculation of 106 T. pallidum (Nichols strain) three months prior
to treatment has been used for the therapeutic assay of penicillin, mapharsen,
and tryparsamide.
2. As tests of cure, the mouse brains were transferred to rabbits six weeks after
treatment.
3. The daily subcutaneous administration of penicillin in peanut oil beeswax
for four days cured in 50% of the animals (CD50) at a total dose of 14,000 units!
Kg., and cured 00% of the animals (CD00) at a total dose of 64,000 units/Kg.
4. Neither mapharsen nor tryparsamide given as single intraperitoneal in-
jections was curative in doses up to the maximum tolerated dose.
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DISCUSSION
DR. EUGENE LORANT: I wish to compliment the author of this paper. I
tried an organic strontium salt and other different compounds to treat the asymp-
tomatic neurosyphilis of the white mouse. (Dott. Eugenio Lorant: Ricerche
Sull'azione di un Sale Organico dello Stronzio in Dermatologia ed in Sifllographia
C. E. D. A. M. Padova 1931). Concerning asymptomatic neurosyphilis in the
white mouse, spirochetes could not be demonstrated. I tried to section a half-
brain of the white mouse in series and looked for spirochetes and inoculated the
other half of the brain into rabbits to see whether spirochetes could be recovered
in a rabbit. I never could find spirochetes in the sectioned part of the brain,
but we could always recover spirochetes in the rabbit, if the white mouse was in-
fected at least from 8 weeks to 8 months. The earlier the infection the more
easily did we recover spirochetes in the rabbit; the later the infection the later
the recovery of the spirochetes in the rabbit. It could be seen that the Spiro-
chetes became virulent through the passage of the white mouse. This brings up
the question of what happens to the spirochete in the white mouse. It would be
possible that there is an invisible form of the Spirochete pallida—-a granular form
or asexual forms. These are the problems confronting research workers in the
past few years. Quite a few papers have been published on spirochetosis o the
white mouse, and I would like to know if anyone has any idea about the possi-
bility of a life cycle of the Spirocheta pallida.
Da. HAROLD J. MAGNUSON: In mouse brains such as these, microscopic exam-
ination usually fails to demonstrate T. pallidum, even though the brains are
known to be infectious. The existence of a granular form of the organism has
been proposed to explain the apparent discrepancy between microscopic and
transfer findings. Since it only requires one spirochete to infect the rabbit, even
the most thorough microscopic examination may fail to demonstrate the in-
fectious inoculum. It is most difficult to rule out the existence of such granular
forms, but I have seen no convincing evidence of their existence.
